ClinVar Miner

Submissions for variant NM_000518.5(HBB):c.-78A>G (rs33931746)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000029960 SCV000052615 pathogenic beta Thalassemia 2011-08-18 criteria provided, single submitter curation Converted during submission to Pathogenic.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000506257 SCV000601318 pathogenic not provided 2017-04-20 criteria provided, single submitter clinical testing
Counsyl RCV000029960 SCV000677933 likely pathogenic beta Thalassemia 2017-06-16 criteria provided, single submitter clinical testing The -28A>G mutation is associated with beta thalassemia.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001000122 SCV001156561 pathogenic not specified 2018-08-24 criteria provided, single submitter clinical testing The HBB c.-78A>G variant (commonly known as -28 (A->G)) is a common beta+ thalassemia variant found in Asian populations (see HbVar link, Yamsri 2011), and has been reported in an individual with beta thalassemia who was homozygous for the variant (Orkin 1983). In addition, functional characterization of the variant indicates a 3-5 fold reduction of beta globin mRNA (Orkin 1983). This variant is listed in the dbSNP database (rs33931746), and is not observed in the general population (1000 Genomes Project). The c.-78A>G variant is located in a conserved region of the beta globin gene promoter and is considered to be pathogenic. REFERENCES Link to HbVar database for -28 (A->G): http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=769 Orkin SH et al. ATA box transcription mutation in beta-thalassemia. Nucleic Acids Res. 1983 Jul 25;11(14):4727-34. Yamsri S et al. Genotype and phenotype characterizations in a large cohort of beta-thalassemia heterozygote with different forms of alpha-thalassemia in northeast Thailand. Blood Cells Mol Dis. 2011 Aug 15;47(2):120-4.
Baylor Genetics RCV001004362 SCV001163300 pathogenic Hb SS disease criteria provided, single submitter clinical testing
OMIM RCV000016729 SCV000036999 pathogenic Beta-plus-thalassemia 1983-07-25 no assertion criteria provided literature only
GeneReviews RCV000029960 SCV000040701 pathogenic beta Thalassemia 2015-05-14 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.